iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Significant Decrease in Short Interest

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a large decline in short interest in May. As of May 31st, there was short interest totalling 1,800 shares, a decline of 85.2% from the May 15th total of 12,200 shares. Approximately 1.2% of the company’s shares are sold short. Based on an average trading volume of 1,100 shares, the days-to-cover ratio is presently 1.6 days.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of NYSEARCA:IBRN opened at $22.86 on Friday. The firm’s 50-day moving average is $21.75 and its two-hundred day moving average is $23.90. iShares Neuroscience and Healthcare ETF has a 1 year low of $17.86 and a 1 year high of $28.74. The firm has a market capitalization of $3.43 million, a PE ratio of 15.90 and a beta of 0.71.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.